Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
10.70
+0.16 (1.52%)
At close: Mar 23, 2026, 4:00 PM EDT
10.60
-0.10 (-0.93%)
After-hours: Mar 23, 2026, 4:00 PM EDT

Ekso Bionics Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12.817.9318.2812.9111.25
Revenue Growth (YoY)
-28.60%-1.94%41.57%14.81%26.62%
Cost of Revenue
5.958.419.26.74.5
Gross Profit
6.859.519.086.216.75
Selling, General & Admin
17.1416.119.1718.1418.03
Research & Development
3.033.875.033.632.55
Total Operating Expenses
20.1719.9724.1921.7720.58
Operating Income
-13.33-10.46-15.11-15.56-13.83
Interest Expense
-0.31-0.27-0.3-0.16-0.11
Other Non-Operating Income (Expense)
1.94-0.60.220.634.18
Total Non-Operating Income (Expense)
1.63-0.87-0.090.484.06
Pretax Income
-11.7-11.33-15.2-15.08-9.76
Net Income
-11.7-11.33-15.2-15.08-9.76
Net Income to Common
-11.7-11.33-15.2-15.08-9.76
Shares Outstanding (Basic)
21111
Shares Outstanding (Diluted)
21111
Shares Change (YoY)
80.51%45.38%6.98%5.65%71.26%
EPS (Basic)
-4.91-8.43-16.50-17.40-12.00
EPS (Diluted)
-4.91-8.43-16.50-17.40-13.20
Free Cash Flow
-11.99-9.88-12.21-14.88-11.22
Free Cash Flow Per Share
-4.94-7.35-13.21-17.22-13.71
Gross Margin
53.48%53.06%49.67%48.13%60.01%
Operating Margin
-104.12%-58.35%-82.67%-120.48%-122.96%
Profit Margin
-91.37%-63.21%-83.14%-116.79%-86.82%
FCF Margin
-93.67%-55.14%-66.80%-115.26%-99.72%
EBITDA
-11.75-8.85-13.41-14.67-12.81
EBITDA Margin
-91.83%-49.38%-73.38%-113.61%-113.86%
EBIT
-13.33-10.46-15.11-15.56-13.83
EBIT Margin
-104.12%-58.35%-82.67%-120.48%-122.96%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q